SI2146714T1 - Uporaba 4-ciklopropilmetoksi-N-(3,5-dikloro-1-oksido-piridin-4-il)-5-(metoksi) priridin-2-karboksamida za zdravljenje motoričnih motenj, povezanih s Parkinsonovo boleznijo - Google Patents
Uporaba 4-ciklopropilmetoksi-N-(3,5-dikloro-1-oksido-piridin-4-il)-5-(metoksi) priridin-2-karboksamida za zdravljenje motoričnih motenj, povezanih s Parkinsonovo boleznijoInfo
- Publication number
- SI2146714T1 SI2146714T1 SI200830357T SI200830357T SI2146714T1 SI 2146714 T1 SI2146714 T1 SI 2146714T1 SI 200830357 T SI200830357 T SI 200830357T SI 200830357 T SI200830357 T SI 200830357T SI 2146714 T1 SI2146714 T1 SI 2146714T1
- Authority
- SI
- Slovenia
- Prior art keywords
- oxidopyridin
- cyclopropylmethoxy
- carboxamide
- parkinson
- dichloro
- Prior art date
Links
- 208000019430 Motor disease Diseases 0.000 title 1
- 208000018737 Parkinson disease Diseases 0.000 title 1
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0702853A FR2915100B1 (fr) | 2007-04-19 | 2007-04-19 | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxalide pour le traitement des desordres moteurs lies a la maladie de parkinson |
| EP08787963A EP2146714B1 (fr) | 2007-04-19 | 2008-04-16 | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson |
| PCT/FR2008/000534 WO2008145841A1 (fr) | 2007-04-19 | 2008-04-16 | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2146714T1 true SI2146714T1 (sl) | 2011-10-28 |
Family
ID=38712405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200830357T SI2146714T1 (sl) | 2007-04-19 | 2008-04-16 | Uporaba 4-ciklopropilmetoksi-N-(3,5-dikloro-1-oksido-piridin-4-il)-5-(metoksi) priridin-2-karboksamida za zdravljenje motoričnih motenj, povezanih s Parkinsonovo boleznijo |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20100130554A1 (OSRAM) |
| EP (1) | EP2146714B1 (OSRAM) |
| JP (1) | JP5386478B2 (OSRAM) |
| KR (2) | KR101503942B1 (OSRAM) |
| CN (1) | CN101663035B (OSRAM) |
| AR (1) | AR066108A1 (OSRAM) |
| AT (1) | ATE513548T1 (OSRAM) |
| AU (1) | AU2008257322B2 (OSRAM) |
| BR (1) | BRPI0810444A2 (OSRAM) |
| CA (1) | CA2684174C (OSRAM) |
| CL (1) | CL2008001136A1 (OSRAM) |
| CY (1) | CY1111840T1 (OSRAM) |
| DK (1) | DK2146714T3 (OSRAM) |
| EA (1) | EA019194B1 (OSRAM) |
| ES (1) | ES2367408T3 (OSRAM) |
| FR (1) | FR2915100B1 (OSRAM) |
| HR (1) | HRP20110666T1 (OSRAM) |
| IL (1) | IL201448A (OSRAM) |
| JO (1) | JO2678B1 (OSRAM) |
| MA (1) | MA31367B1 (OSRAM) |
| ME (1) | ME00935B (OSRAM) |
| MX (1) | MX2009011284A (OSRAM) |
| MY (1) | MY148092A (OSRAM) |
| NZ (1) | NZ580482A (OSRAM) |
| PA (1) | PA8776801A1 (OSRAM) |
| PL (1) | PL2146714T3 (OSRAM) |
| PT (1) | PT2146714E (OSRAM) |
| RS (1) | RS51869B (OSRAM) |
| SI (1) | SI2146714T1 (OSRAM) |
| TW (1) | TWI439269B (OSRAM) |
| UY (1) | UY31035A1 (OSRAM) |
| WO (1) | WO2008145841A1 (OSRAM) |
| ZA (1) | ZA200907251B (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016500094A (ja) * | 2012-11-28 | 2016-01-07 | サノフイ | ４−（シクロプロピルメトキシ）−ｎ−（３，５−ジクロロ−１−オキシドピリジン−４−イル）−５−メトキシピリジン−２−カルボキサミドの結晶形態の製造方法およびその結晶形態 |
| US9624100B2 (en) | 2014-06-12 | 2017-04-18 | Apple Inc. | Micro pick up array pivot mount with integrated strain sensing elements |
| WO2025079694A1 (ja) * | 2023-10-12 | 2025-04-17 | 株式会社 メドレックス | 経皮吸収組成物 |
| US20250120957A1 (en) * | 2023-10-12 | 2025-04-17 | Alto Neuroscience, Inc. | Treatment of neuropsychiatric disorders with tilivapram |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4193926A (en) * | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
| JP3775685B2 (ja) * | 1993-07-28 | 2006-05-17 | ローン−プーラン・ロレ・リミテツド | Ｐｄｅ▲ｉｖ▼およびｔｎｆ抑制剤としての化合物 |
| US6177077B1 (en) * | 1999-02-24 | 2001-01-23 | Edward L. Tobinick | TNT inhibitors for the treatment of neurological disorders |
| PT1244649E (pt) * | 1999-12-23 | 2005-06-30 | Icos Corp | Inibidores de fosfodiesterase especificos de mfa ciclica |
| HUP0600103A2 (en) * | 2001-03-02 | 2006-06-28 | Bristol Myers Squibb Co | Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| JP2005538972A (ja) * | 2002-07-02 | 2005-12-22 | メルク フロスト カナダ アンド カンパニー | ジアリール置換エタンピリドンｐｄｅ４阻害剤 |
| ES2362484T3 (es) * | 2003-03-12 | 2011-07-06 | Celgene Corporation | Compuestos de ácido n-alquil-hidroxámico-isoindolilo y sus usos farmacéuticos. |
| AU2006257863A1 (en) * | 2005-06-10 | 2006-12-21 | F. Hoffmann-La Roche Ag | Trisubstituted amines as phosphodiesterase 4 inhibitors |
| US20070021451A1 (en) * | 2005-07-20 | 2007-01-25 | Hamamatsu University School Of Medicine | Method for preventing or treating neurologic damage after spinal cord injury |
-
2007
- 2007-04-19 FR FR0702853A patent/FR2915100B1/fr not_active Expired - Fee Related
-
2008
- 2008-04-15 PA PA20088776801A patent/PA8776801A1/es unknown
- 2008-04-16 BR BRPI0810444A patent/BRPI0810444A2/pt not_active IP Right Cessation
- 2008-04-16 MY MYPI20094343A patent/MY148092A/en unknown
- 2008-04-16 ES ES08787963T patent/ES2367408T3/es active Active
- 2008-04-16 MX MX2009011284A patent/MX2009011284A/es active IP Right Grant
- 2008-04-16 KR KR1020097021593A patent/KR101503942B1/ko not_active Expired - Fee Related
- 2008-04-16 AT AT08787963T patent/ATE513548T1/de active
- 2008-04-16 CN CN2008800126498A patent/CN101663035B/zh not_active Expired - Fee Related
- 2008-04-16 HR HR20110666T patent/HRP20110666T1/hr unknown
- 2008-04-16 WO PCT/FR2008/000534 patent/WO2008145841A1/fr not_active Ceased
- 2008-04-16 KR KR1020147033000A patent/KR20150004885A/ko not_active Ceased
- 2008-04-16 NZ NZ580482A patent/NZ580482A/en not_active IP Right Cessation
- 2008-04-16 AU AU2008257322A patent/AU2008257322B2/en not_active Ceased
- 2008-04-16 RS RS20110358A patent/RS51869B/sr unknown
- 2008-04-16 PL PL08787963T patent/PL2146714T3/pl unknown
- 2008-04-16 SI SI200830357T patent/SI2146714T1/sl unknown
- 2008-04-16 ME MEP-2009-299A patent/ME00935B/me unknown
- 2008-04-16 PT PT08787963T patent/PT2146714E/pt unknown
- 2008-04-16 DK DK08787963.1T patent/DK2146714T3/da active
- 2008-04-16 EP EP08787963A patent/EP2146714B1/fr active Active
- 2008-04-16 JP JP2010503549A patent/JP5386478B2/ja not_active Expired - Fee Related
- 2008-04-16 CA CA2684174A patent/CA2684174C/fr not_active Expired - Fee Related
- 2008-04-16 EA EA200970970A patent/EA019194B1/ru not_active IP Right Cessation
- 2008-04-17 TW TW097113997A patent/TWI439269B/zh not_active IP Right Cessation
- 2008-04-17 JO JO2008182A patent/JO2678B1/en active
- 2008-04-18 CL CL2008001136A patent/CL2008001136A1/es unknown
- 2008-04-18 UY UY31035A patent/UY31035A1/es not_active Application Discontinuation
- 2008-04-18 AR ARP080101602A patent/AR066108A1/es unknown
-
2009
- 2009-10-05 US US12/573,326 patent/US20100130554A1/en not_active Abandoned
- 2009-10-11 IL IL201448A patent/IL201448A/en not_active IP Right Cessation
- 2009-10-16 ZA ZA2009/07251A patent/ZA200907251B/en unknown
- 2009-11-10 MA MA32333A patent/MA31367B1/fr unknown
-
2011
- 2011-09-15 CY CY20111100887T patent/CY1111840T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200909191B (en) | Catecholamine derivatives useful for the treatment of parkinson's disease | |
| BRPI0818799A2 (pt) | Composições para o tratamento da doença de parkinson | |
| EP2166837A4 (en) | DRUG COMBINATION USEFUL FOR THE TREATMENT OF SKIN DISORDERS | |
| IL208607A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
| IL195906A0 (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
| PL2229369T3 (pl) | Pochodne 6,7-dialkoksychinazoliny użyteczne do leczenia zaburzeń związanych z rakiem | |
| AU2008233088A8 (en) | Calcimimetic compounds for use in the treatment of bowel disorders | |
| IL206107A0 (en) | Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders | |
| SI2146714T1 (sl) | Uporaba 4-ciklopropilmetoksi-N-(3,5-dikloro-1-oksido-piridin-4-il)-5-(metoksi) priridin-2-karboksamida za zdravljenje motoričnih motenj, povezanih s Parkinsonovo boleznijo | |
| IL201451A0 (en) | Use of 4 - cyclopropylmethoxy - n - (3, 5 - dichloro - 1 - oxidopyridin - 4 - yl) - 5 - (methoxy) pyridine - 2 - carboxamide for the treatment of spinal cord traumas | |
| EP2214488A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS | |
| GB0710277D0 (en) | Use of antivirals in the treatment of medical disorders | |
| BRPI0714307A2 (pt) | Uso de benzamidas trifluormetil-substituídas no tratamento de distúrbios neurológicos | |
| EP2099444A4 (en) | USE OF D-SERIN DERIVATIVES FOR THE TREATMENT OF ANTIBODIES | |
| IL201447A0 (en) | Use of 4 - cyclopropylmethoxy - n - (3, 5 - dichloro - 1 - oxidopyridin - 4 - yl) - 5 - (methoxy) pyridine - 2 - carboxamide for the treatment of cranial traumas | |
| IL198432A0 (en) | 2-alkyl-indazole compounds for the treatment of certain cns-related disorders |